Slovenia vs United States: Proportion of isolates with decreased susceptibility or resistance
Slovenia
0
in 2020
United States
0
in 2020
Slovenia rank
13th
United States rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Slovenia
- United States
How they compare
Slovenia currently reports 0 against 0 in United States, a difference of 0.
The two have swapped places 2 times across 10 shared years of data; in 2009 it was United States ahead.
Slovenia ranks 13th and United States ranks 13th of 52 countries.
Across the 3 decades both report, Slovenia averaged higher in 1 and United States in 1.
Head to head by decade
| Decade | Slovenia | United States | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.2842 | 0.2842 | United States |
| 2010s | 0.266 | 0.244 | 0.022 | Slovenia |
| 2020s | 0 | 0 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Slovenia or United States?
- Slovenia, at 0 against 0 in United States as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Slovenia and United States?
- 0, with Slovenia ahead.
- How many years of comparable data are there for Slovenia and United States?
- 10 years are reported by both, from 2009 to 2020.
- How do Slovenia and United States rank globally for proportion of isolates with decreased susceptibility or resistance?
- Slovenia ranks 13th and United States ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.